JP Morgan assigns 418 points UnitedHealth Group (UNH) to overweight rating
UnitedHealth Group Incorporated (NYSE:UNH) is one of Most underrated blue chip stock to buy according to hedge funds. JP Morgan Analyst Lisa Gill assigns an overweight rating to UnitedHealth Group Incorporated (NYSE: UNH) with a price target of $418, suggesting that he could rebound 48% over the next 12 months.
A senior medical professional who gives advice to clinic patients.
She said the company’s transition from “unaware” in February to “actively collaborating” with the Department of Justice is no surprise. Analysts expressed optimism for UnitedHealth Group Incorporated (NYSE: UNH).
“We are not lawyers, but we believe that if the court saw this case as in the previous cases filed by the DOJ regarding the False Claims Act (FCA), this will put a burden on the DOJ to prove inappropriate coding.”
UnitedHealth Group Incorporated (NYSE: UNH) offers healthcare coverage, data consultancy and software services. Works through Optumrx, Optuminsight, OptumHealth, and UnitedHealthCare segments.
Although we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater promotion potential and pose a risk of decline. If you’re looking for a highly undervalued AI stock that can make a significant profit from the tariff and supervision trends of the Trump era, check out our free report. Best Short-Term AI Stocks.
Read next: 30 stocks that double in three years and 11 Hidden AI Strains Buy Now.
Disclosure: None. This article was originally published Insider Monkey.